- Home
- BKU vs BSX Comparison
BKU vs BSX Comparison
Compare BKU & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKU | BSX |
|---|---|---|
| Founded | 2009 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 137.8B |
| IPO Year | 2011 | 1992 |
Fundamental Metrics
Financial Performance| Metric | BKU | BSX |
|---|---|---|
| Price | $44.98 | $99.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 17 |
| Target Price | $43.45 | ★ $125.88 |
| AVG Volume (30 Days) | 749.2K | ★ 9.2M |
| Earning Date | 01-21-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | 44.85 | ★ 54.68 |
| EPS | ★ 3.54 | 1.87 |
| Revenue | $1,016,093,000.00 | ★ $19,349,000,000.00 |
| Revenue This Year | $14.68 | $21.05 |
| Revenue Next Year | $5.82 | $11.44 |
| P/E Ratio | ★ $12.86 | $52.29 |
| Revenue Growth | 10.45 | ★ 21.61 |
| 52 Week Low | $28.21 | $85.98 |
| 52 Week High | $46.92 | $109.50 |
Technical Indicators
Market Signals| Indicator | BKU | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 55.78 | 60.86 |
| Support Level | $43.87 | $93.86 |
| Resistance Level | $46.00 | $96.33 |
| Average True Range (ATR) | 0.80 | 1.45 |
| MACD | -0.21 | 0.52 |
| Stochastic Oscillator | 45.53 | 98.92 |
Price Performance
Historical ComparisonAbout BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.